Results 191 to 198 of about 20,820 (198)

Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus

Antiviral Research, 2016
Adrian S Ray, Michael Jm Hitchcock
exaly  

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

New England Journal of Medicine, 2015
Jeanne M Marrazzo, Gonasagrie Nair, Ariane van der Straten   +2 more
exaly  

Tenofovir disoproxil fumarate

Reactions Weekly, 2012
openaire   +1 more source

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Journal of Hepatology, 2018
Kosh Agarwal, Young-Suk Lim, Scott Fung
exaly  

Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence

American Journal of Kidney Diseases, 2011
Andrew M Hall, Dorothea Nitsch
exaly  

Tenofovir disoproxil fumarate

Reactions Weekly, 2006
openaire   +1 more source

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Antimicrobial Agents and Chemotherapy, 2018
Peter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla   +2 more
exaly  

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study

Clinical Infectious Diseases, 2020
exaly